Biopharmaceutical Contract Manufacturing Market 2020-2026 Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis and Forecast By 2026
Biopharmaceutical Contract Manufacturing Market – Insights
Contract manufacturing organizations (CMOs) offer various manufacturing services such as contract packaging, quality testing, and product development to pharmaceutical and biotechnology industries. Complexity in manufacturing process of biomolecules, owing to their different shapes, sizes, and behaviors has led biopharmaceutical companies to prefer CMOs. CMOs offer biologics development and commercialization services along with cell line development, fermentation, process optimization, and analytical characterization.
Request A FREE Sample Copy – Biopharmaceutical Contract Manufacturing Market Report Click here: https://www.coherentmarketinsights.com/insight/request-sample/1077
Global Biopharmaceutical Contract Manufacturing Market Taxonomy:
On the basis of contract type, product type, and therapeutic application, global biopharmaceutical contract manufacturing market is segmented into:
By Contract Type:
- Active Pharmaceutical Ingredient (API)
By Product Type:
- Monoclonal Antibodies
- Recombinant Hormone
By Therapeutic Applications:
- Autoimmune Diseases
- Metabolic Diseases
- Cardiovascular Diseases
- Infectious Diseases
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1077
Global Biopharmaceutical Contract Manufacturing Market: Drivers
Improved efficiency of CMOs and increasing price pressure, weak product pipeline, and increasing outsourcing services in the biopharmaceutical sector is expected to boost growth of the global biopharmaceutical contract manufacturing market over the forecast period. According to the annual report of BioPlan Associates, 2017, increasing international manufacturing centers, which include China, expansion of biosimilars, and approval of cell-and-gene therapy is expected to boost growth of the market.
According to the Journal of Pharmaceutical Manufacturing in 2017, focus on reducing risk by outsourcing with other biopharma to achieve efficient product in minimum time interval, switching over the large biopharma companies to strengthen the weak pipeline product, and on reducing costs of product development without risking financial investments are major factors boosting growth of the biopharmaceutical contract manufacturing market. Moreover, CMOs offer services to companies lacking the capability to develop formula or product.
Key players in the market are focused on adopting collaboration strategies, which is also expected to boost growth of the market. For instance, in September 2017, Pelican Therapeutics and subsidiary of Heat Biologics entered into a manufacturing agreement with KBI Biopharma. According to the agreement, KBI Biopharma will provide development and manufacturing service under biopharmaceutical contract development and manufacturing organization (CDMO) for cGMP production of an antibody (PTX-35) and a fusion protein (PTX-15). Pelican Therapeutics intends to develop immunotherapy drugs by mimicking the production of antigen-specific T-cells. Moreover, increasing investment in cancer research is also expected to propel growth of the market. For instance, in May 2016, Pelican Therapeutics received a grant of US$ 15.2 million from the Cancer Prevention and Research Institute of Texas (CPRIT) for manufacturing of immunotherapies for lung, pancreatic, lymphoma, prostate, and ovarian cancers.
Global Biopharmaceutical Contract Manufacturing Market: Competitive Landscape
Key players in the market are focused on expanding the service portfolio. For instance, in September 2017, Ajinomoto Althea, Inc. announced a GMP production suite in newly established High Potency Products (HPP) manufacturing site located in San Diego, California, U.S. Currently, Althea is offering process development and analytical services to the clients and from November 2017, the company will provide facilities for GMP manufacturing of bioconjugation and complex formulation. Apart from this services, Althea is also focused on offering full manufacturing services including fill-and-finish, which will start off in 2018.
Got any Query? Feel free to ask us at https://www.coherentmarketinsights.com/insight/talk-to-analyst/1077
Key players in the market are also focused on gaining contracts to enhance their market share. For instance, in September 2017, Achaogen, Inc. received US$ 18 million contract from Biomedical Advanced Research and Development Authority (BARDA) to support development of orally-administered antibacterial candidate C-Scape. It is an orally administered antibacterial candidate developed for the treatment of bacterial infections caused by the family of Enterobacteriaceae producing Extended Spectrum Beta-Lactamase (ESBL).
Major players operating in the global biopharmaceutical contract manufacturing market include, Boehringher Ingelheim, BIOMEVA GmbH, Lonza Group Ltd., ProBioGen AG, Celonic GmbH, Rentschler Biotechnologie, Sandoz, and Fujifilm Diosynth Biotechnology.About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire